COM:ATARABIO
Atara Biotherapeutics Inc
- Stock
Last Close
10.61
22/11 21:00
Market Cap
44.24M
Beta: -
Volume Today
65.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 20.34M - | 63.57M 212.55% | 8.57M 86.51% | |||||||||
cost of revenue | 8.89M - | |||||||||||
gross profit | 20.34M - | 63.57M 212.55% | -313K 100.49% | |||||||||
selling and marketing expenses | -1.11M - | |||||||||||
general and administrative expenses | 3.76M - | 12.71M 238.39% | 16.83M 32.42% | 24.73M 46.93% | 40.33M 63.08% | 69.65M 72.73% | 79.58M 14.26% | 64.40M 19.08% | 78.80M 22.36% | 71.55M 9.20% | 50.91M 28.85% | |
selling general and administrative expenses | 3.76M - | 12.71M 238.39% | 16.83M 32.42% | 24.73M 46.93% | 40.33M 63.08% | 69.65M 72.73% | 79.58M 14.26% | 64.40M 19.08% | 78.80M 22.36% | 71.55M 9.20% | 49.80M 30.41% | |
research and development expenses | 4.86M - | 15.45M 217.88% | 41.62M 169.44% | 56.51M 35.79% | 81.21M 43.69% | 167.46M 106.21% | 216.10M 29.05% | 244.65M 13.21% | 282.00M 15.27% | 272.53M 3.36% | 219.17M 19.58% | |
other expenses | 1.07M - | -246K - | ||||||||||
cost and expenses | 8.62M - | 28.16M 226.83% | 58.45M 107.59% | 81.24M 39.00% | 121.53M 49.59% | 237.11M 95.10% | 295.68M 24.70% | 309.05M 4.52% | 360.80M 16.74% | 344.09M 4.63% | 277.85M 19.25% | |
operating expenses | 8.62M - | 28.16M 226.83% | 58.45M 107.59% | 81.24M 39.00% | 121.53M 49.59% | 237.11M 95.10% | 295.68M 24.70% | 309.05M 4.52% | 360.80M 16.74% | 344.09M 4.63% | 268.96M 21.83% | |
interest expense | 1.99M - | 5.29M 166.11% | ||||||||||
ebitda | -8.61M - | -28.16M 226.98% | -58.45M 107.59% | -81.24M 39.00% | -121.53M 49.59% | -237.11M 95.10% | -295.68M 24.70% | -309.05M 4.52% | -340.46M 10.16% | -330.75M 2.85% | -264.45M 20.05% | |
operating income | -8.62M - | -28.16M 226.83% | -58.45M 107.59% | -81.24M 39.00% | -121.53M 49.59% | -237.11M 95.10% | -295.68M 24.70% | -309.05M 4.52% | -340.46M 10.16% | -280.51M 17.61% | -269.28M 4.01% | |
depreciation and amortization | 4K - | 6K 50% | 48K 700% | 383K 697.92% | 956K 149.61% | 3.73M 290.38% | 7.07M 89.44% | 8.33M 17.85% | 9.35M 12.16% | -50.24M 637.58% | 4.83M 109.61% | |
total other income expenses net | 12K - | 125K 941.67% | 1.22M 874.40% | 2.20M 80.87% | 2.03M 7.99% | 6.37M 214.16% | 4.72M 25.93% | 2.45M 48.12% | 367K 85.00% | 52.22M 14,129.70% | -6.83M 113.09% | |
income before tax | -8.60M - | -28.03M 225.83% | -57.23M 104.17% | -79.04M 38.11% | -119.50M 51.20% | -230.74M 93.08% | -290.96M 26.10% | -306.61M 5.38% | -340.10M 10.92% | -228.29M 32.87% | -276.11M 20.95% | |
income tax expense | 170K - | -25K 114.71% | -9K 64% | 10K 211.11% | -14K 240% | -44K 214.29% | 12K 127.27% | 15K 25% | 46K 206.67% | 12K 73.91% | 15K 25% | |
net income | -8.77M - | -28.01M 219.23% | -57.22M 104.32% | -79.05M 38.15% | -119.49M 51.16% | -230.70M 93.07% | -290.98M 26.13% | -306.62M 5.38% | -340.14M 10.93% | -228.30M 32.88% | -276.13M 20.95% | |
weighted average shs out | 6.87M - | 4.99M 27.44% | 25.58M 413.14% | 28.73M 12.31% | 29.86M 3.94% | 43.81M 46.71% | 51.31M 17.11% | 73.97M 44.17% | 93.67M 26.63% | 101.99M 8.88% | 105.91M 3.85% | |
weighted average shs out dil | 6.87M - | 4.99M 27.44% | 25.58M 413.14% | 28.73M 12.31% | 29.86M 3.94% | 43.81M 46.71% | 51.31M 17.11% | 73.97M 44.17% | 93.67M 26.63% | 101.99M 8.88% | 105.91M 3.85% | |
eps | -1.28 - | -5.62 339.06% | -2.24 60.14% | -2.75 22.77% | -4 45.45% | -5.27 31.75% | -5.67 7.59% | -4.15 26.81% | -3.63 12.53% | -2.24 38.29% | -2.61 16.52% | |
epsdiluted | -1.28 - | -5.62 339.06% | -2.24 60.14% | -2.75 22.77% | -4 45.45% | -5.27 31.75% | -5.67 7.59% | -4.15 26.81% | -3.63 12.53% | -2.24 38.29% | -2.61 16.52% |
All numbers in (except ratios and percentages)